General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

Akero Therapeutics ×

Akero Therapeutics is a clinical stage biotechnology company developing novel therapies for patients with non-alcoholic steatohepatitis (NASH).

  • Sector: Life Sciences
  • Headquarters: South San Francisco, CA
  • Date Invested: 05/18/2023
  • Visit Website